Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arzoxifene vs Tamoxifen in High-Risk Premenopausal Women
NCT00253539Phase 2Completed
- Sponsor
- Cleveland Clinic
- Start
- Jan 2002
- Primary completion
- Apr 2005
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of arzoxifene in breast cancer (3 arms), sponsored by Cleveland Clinic. Primary endpoint: Ki67 in breast tissue. Started Jan 2002; status: completed.
02
Drugs
arzoxifene
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00253539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00253539.